基本信息
文件名称:Scr-IN-1-生命科学试剂-MCE.pdf
文件大小:474.96 KB
总页数:1 页
更新时间:2025-03-19
总字数:约2.05千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Scr-IN-1

Cat.No.:HY-170958

分?式:C??H??ClF?N?O?

分?量:496.87

作?靶点:Src;Apoptosis

作?通路:ProteinTyrosineKinase/RTK;Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Scr-IN-1(Compound4e)是?种酪氨酸激酶(Tyrosinekinase)抑制剂。它对HCT-116细胞和MIA-PaCa-2细胞

的抑制活性IC50值分别为0.16μM和1.16μM。Scr-IN-1在HCT-116细胞和MIA-PaCa-2细胞上表现出选择

性,选择性指数(SI)分别?于625和86。Scr-IN-1可诱导HCT-116结肠癌细胞发?凋亡Apoptosis,且不会引

起坏死细胞?例的变化。Scr-IN-1可能是?种新型的HCT-116细胞SRC激酶抑制剂。Scr-IN-1适?于癌症研究

REFERENCES

[1].Camc?-ErenM,etal.New2-indolinone-indolehybridcompoundscarryingabenzoylmoietyastyrosinekinaseinhibitors.BioorgChem.

2025Mar;156:108203.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1Mast